MITBX
Price
$35.93
Change
+$0.12 (+0.34%)
Updated
Aug 21 closing price
Net Assets
6.97B
VSMPX
Price
$345.48
Change
+$1.68 (+0.49%)
Updated
Aug 21 closing price
Net Assets
2.29T
Interact to see
Advertisement

MITBX vs VSMPX

MITBX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
MITBX vs. VSMPX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MITBX is a StrongBuy and VSMPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.29T vs. MITBX (6.97B). VSMPX pays higher dividends than MITBX: VSMPX (1.07) vs MITBX (0.00). MITBX was incepted earlier than VSMPX: MITBX (33 years) vs VSMPX (11 years). MITBX (1.44) is less costly to investors than VSMPX (0.02). MITBX is a more actively managed with annual turnover of: 26.00 vs. VSMPX (3.00). MITBX has a lower initial minimum investment than VSMPX: MITBX (1000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.03 vs. MITBX (1.53). VSMPX return over 5 years is better than : 66.62 vs. MITBX (-12.79).
MITBXVSMPXMITBX / VSMPX
Total Expense Ratio1.440.027,200%
Annual Report Gross Expense Ratio1.440.027,200%
Fund Existence33 years11 years-
Gain YTD9.04412.87670%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.97B2.29T0%
Annual Yield % from dividends0.001.07-
Returns for 1 year1.5321.037%
Returns for 3 years8.6474.3312%
Returns for 5 years-12.7966.62-19%
Returns for 10 years28.18238.8312%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCEX105.501.05
+1.01%
Rydex Europe 1.25x Strategy C
LVAVX17.340.12
+0.70%
LSV Conservative Value Equity Investor
NWAEX20.360.08
+0.39%
Nationwide BNY Mellon Dyn US Core Eagle
WWIAX13.510.03
+0.22%
Westwood Income Opportunity A
JFNSX87.14N/A
N/A
Janus Henderson Global Life Sciences S